Sustaining obesity prevention in communities: a systematic narrative synthesis review

by Whelan, J, Love, P, Millar, Lynne, Allender, S, Bell, C
Published 2018

Sleep duration and risk of obesity among a sample of Victorian school children

by Morrissey, B, Malakellis, M, Whelan, J, Millar, Lynne, Swinburn, B, Allender, S, Strugnell, C
Published 2016

You Can’t Find Healthy Food in the Bush: Poor Accessibility, Availability and Adequacy of Food in Rural Australia

by Whelan, J, Millar, Lynne, Bell, C, Russell, C, Grainger, F, Allender, S, Love, P
Published 2018

Parental Translation into Practice of Healthy Eating and Active Play Messages and the Impact on Childhood Obesity: A Mixed Methods Study

by Huxtable, A, Millar, Lynne, Love, P, Bell, C, Whelan, J
Published 2018

Causal inference with randomised clinical trials of chemotherapy: the importance of well-documented treatment side-effects

by Lancia, C., Spitoni, C., Anninga, J., Whelan, J., Sydes, M.R., Jovic, G., Fiocco, M.
Published 2017

A Transcriptomic Signature of Mouse Liver Progenitor Cells

by Passman, A.M, Low, J, London, R, Tirnitz-Parker, J.E.E, Miyajima, A, Tanaka, M, Strick-Marchand, H, Darlington, G.J, Finch-Edmondson, M, Ochsner, S, Zhu, C, Whelan, J, Callus, B.A, Yeoh, G.C.T
Published 2020

ENCCAWP17-WP7 consensus paper on teenagers and young adults (TYA) with bone sarcomas

by Wilhelm, M., Dirksen, U., Bielack, S.S., Whelan, J.S., Lewis, I.J., Jurgens, H., Ferrari, S., Hall, K.S., Cleton-Jansen, A.M., Stark, D.
Published 2014

Method to measure the mismatch between target and achieved received dose intensity of chemotherapy in cancer trials: a retrospective analysis of the MRC BO06 trial in osteosarcoma

by Lancia, C., Anninga, J., Spitoni, C., Sydes, M.R., Whelan, J., Hogendoorn, P.C.W., Gelderblom, H., Fiocco, M.
Published 2019

EURAMOS-1 study: Recruitment, characteristics, and initial treatment of more than 2,000 patients (pts) with high-grade osteosarcoma

by Whelan, J., Hook, J., Bielack, S.S., Marina, N., Smeland, S., Jovic, G., Krailo, M.D., Kuhne, T., Eriksson, M., Butterfass-Bahloul, T., Teot, L.A., Kager, L., Gelderblom, H., Hall, K.S., Hogendoorn, P.C.W., Sydes, M.R., Bernstein, M.L., EURAMOS
Published 2012

Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis

by Collins, M., Wilhelm, M., Conyers, R., Herschtal, A., Whelan, J., Bielack, S., Kager, L., Kuhne, T., Sydes, M., Gelderblom, H., Ferrari, S., Picci, P., Smeland, S., Eriksson, M., Petrilli, A.S., Bleyer, A., Thomas, D.M.
Published 2013

Survival after recurrent osteosarcoma: Data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials

by Gelderblom, H., Jinks, R.C., Sydes, M., Bramwell, V.H.C., Glabbeke, M. van, Grimer, R.J., Hogendoorn, P.C.W., McTiernan, A., Lewis, I.J., Nooij, M.A., Taminiau, A.H.M., Whelan, J., European Osteosarcoma Intergrp
Published 2011

Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy

by Calaminus, G., Jenney, M., Hjorth, L., Baust, K., Bernstein, M., Bielack, S., Vos, P. de, Hogendoorn, P.C.W., Jovic, G., Krailo, M., Kreitz, K., Marina, N., Popoola, B.O., Sauerland, C., Smeland, S., Teske, C., Schweinitz, C.V., Whelan, J., Wiener, A., Sydes, M.R., Nagarajan, R.
Published 2019

A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in...

by Lancia, C., Anninga, J.K., Sydes, M.R., Spitoni, C., Whelan, J., Hogendoorn, P.C.W., Gelderblom, H., Fiocco, M.
Published 2019

MAP plus maintenance pegylated interferon alpha-2b (MAP-IFN) versus MAP alone in patients (pts) with resectable high-grade osteosarcoma and good histologic response to preoperative...

by Bielack, S.S., Smeland, S., Whelan, J., Marina, N., Hook, J., Jovic, G., Krailo, M.D., Butterfass-Bahloul, T., Kuhne, T., Eriksson, M., Teot, L.A., Gelderblom, H., Kager, L., Hall, K.S., Gorlick, R.G., Randall, R.L., Hogendoorn, P.C.W., Calaminus, G., Sydes, M.R., Bernstein, M.L.
Published 2013

MAP plus maintenance pegylated interferon alpha-2b (MAPIfn) versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: F...

by Bielack, S.S., Smeland, S., Whelan, J., Marina, N., Hook, J., Jovic, G., Krailo, M.D., Butterfass-Bahloul, T., Kuhne, T., Eriksson, M., Teot, L.A., Gelderblom, H., Kager, L., Hall, K.S., Gorlick, R.G., Randall, R.L., Hogendoorn, P.C.W., Calaminus, G., Sydes, M.R., Bernstein, M.L.
Published 2013

Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

by Hogendoorn, P.C.W., Athanasou, N., Bielack, S., Alava, E. de, Tos, A.P.D., Ferrari, S., Gelderblom, H., Grimer, R., Hall, K.S., Hassan, B., Jurgens, H., Paulussen, M., Rozeman, L., Taminiau, A.H.M., Whelan, J., Vanel, D., ESMO EUROBONET Working Grp
Published 2010

Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the Eur...

by McTiernan, A., Jinks, R.C., Sydes, M.R., Uscinska, B., Hook, J.M., Glabbeke, M. van, Bramwell, V., Lewis, I.J., Taminiau, A.H.M., Nooij, M.A., Hogendoorn, P.C.W., Gelderblom, H., Whelan, J.S.
Published 2012

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

by Whelan, J.S., Jinks, R.C., McTiernan, A., Sydes, M.R., Hook, J.M., Trani, L., Uscinska, B., Bramwell, V., Lewis, I.J., Nooij, M.A., Glabbeke, M. van, Grimer, R.J., Hogendoorn, P.C.W., Taminiau, A.H.M., Gelderblom, H.
Published 2012

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

by Judson, I., Verweij, J., Gelderblom, H., Hartmann, J.T., Schoffski, P., Blay, J.Y., Kerst, J.M., Sufliarsky, J., Whelan, J., Hohenberger, P., Krarup-Hansen, A., Alcindor, T., Marreaud, S., Litiere, S., Hermans, C., Fisher, C., Hogendoorn, P.C.W., Tos, A.P. dei, Graaf, W.T.A. van der, European Org, Treatment Canc Soft Tissue Bone Sa
Published 2014

Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and...

by Fresneau, B., Hackshaw, A., Hawkins, D.S., Paulussen, M., Anderson, J.R., Judson, I., Litiere, S., Dirksen, U., Lewis, I., Berg, H. van den, Gaspar, N., Gelderblom, H., Whelan, J., Boddy, A.V., Wheatley, K., Pignon, J.P., Vathaire, F. de, Deley, M.C. le, Teuff, G. le
Published 2017